Clinical Study
Nutrition Support for Head and Neck Squamous Cell Carcinoma Patients Treated with Chemoradiotherapy: How Often and How Long?
| | Nutrition supported | Not supported | value | | (45%) | (55%) |
| Male/female | 24/0 | 25/4 | 0.21 | Age (range) | 60 (45–77) | 60 (47–74) | | OP/HP/L | 5/13/6 | 17/11/1 | | T1,2,3/4 | 16/8 | 16/13 | 0.51 | N0,1,2a/2b,2c,3 | 8/16 | 4/25 | 0.2 | Stage II, III/IV | 5/19 | 2/27 | 0.15 | Chemotherapy regimen (including 5-FU/without 5-FU) | 17/13 | 16/7 | 0.33 | Resectability (yes/no) | 10/19 | 11/13 | 0.4 |
|
|
Over 70 versus under 69. OP versus HP.
|